===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------
SCHEDULE 13D
(Amendment No. 1)*
EVOLVE SOFTWARE, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.001 Par Value
--------------------------------------------------------------------------------
(Title of Class of Securities)
30049P104
--------------------------------------------------------------------------------
(CUSIP Number)
Scott A. Arenare, Esq.
Vice President and General Counsel
Warburg Pincus LLC
466 Lexington Avenue
New York, New York 10017
(212) 878-0600
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of
Person Authorized to Receive Notices
and Communications)
Copies to:
Francis S. Currie, Esq.
Davis Polk & Wardwell
1600 El Camino Real
Menlo Park, California 94025
(650) 752-2000
October 9, 2001
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
-----------------------
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [_].
Note. Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7 for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following pages)
CUSIP No. 30049P104
13D
-------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Warburg Pincus Private Equity VIII, L.P. I.R.S. #13-416869
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |X|
3 SEC USE ONLY
4 SOURCE OF FUNDS*
WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) [_]
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY OWNED BY EACH 0
REPORTING PERSON WITH
8 SHARED VOTING POWER
62,773,430(1)
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
50,003,298(2)
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
62,773,430(1)
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [_]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
68.1%(3)
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
[*SEE INSTRUCTIONS BEFORE FILLING OUT!]
--------------------------------------------------------------------------------
--------
(1) Includes (i) 20,000,000 shares of Common Stock that may be acquired at
any time upon the conversion of Series A Preferred Stock currently held by
Warburg Pincus Private Equity VIII, L.P. and 30,000,000 shares of Common Stock
that may be acquired within 60 days pursuant to the Preferred Stock Warrants
and Common Stock Warrants (discussed in Items 3-5); (ii) 10,770,132 shares of
Common Stock currently held by certain other stockholders of the issuer that
are subject to the Voting Agreement (discussed in Item 6) and 2,000,000 shares
of Common Stock that may be acquired at any time by those stockholders upon the
conversion of Series A Preferred Stock and (iii) 3,298 shares of Common Stock
owned by a Member and Managing Director of Warburg Pincus LLC and Partner of
Warburg Pincus & Co.
(2) Includes 20,000,000 shares of Common Stock that may be acquired at any
time upon the conversion of Series A Preferred Stock and 30,000,000 shares of
Common Stock that may be acquired within 60 days pursuant to the Preferred
Stock Warrants and Common Stock Warrants and 3,298 shares of Common Stock owned
by a Member and Managing Director of Warburg Pincus LLC and Partner of Warburg
Pincus & Co.
(3) Calculated in accordance with Rule 13d-3 under the Exchange Act, based
upon the number of shares of Common Stock outstanding as of August 31, 2001 (as
represented by the issuer in the Purchase Agreement), shares issuable upon
conversion of Series A Preferred stock issued and outstanding on the date
hereof and including shares issuable within 60 days to the Reporting Persons.
--------------------------------------------------------------------------------
CUSIP No. 30049P104
13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Warburg Pincus & Co. I.R.S. #13-6358475
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |X|
3 SEC USE ONLY
4 SOURCE OF FUNDS*
N/A
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |X|
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY OWNED BY EACH 0
REPORTING PERSON WITH
8 SHARED VOTING POWER
62,773,430(1)
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
50,003,298(2)
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
62,773,430(1)
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* |_|
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
68.1%(3)
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
[*SEE INSTRUCTIONS BEFORE FILLING OUT!]
--------
(1) Includes (i) 20,000,000 shares of Common Stock that may be acquired at
any time upon the conversion of Series A Preferred Stock currently held by
Warburg Pincus Private Equity VIII, L.P. and 30,000,000 shares of Common Stock
that may be acquired within 60 days pursuant to the Preferred Stock Warrants
and Common Stock Warrants (discussed in Items 3-5); (ii) 10,770,132 shares of
Common Stock currently held by certain other stockholders of the issuer that
are subject to the Voting Agreement (discussed in Item 6) and 2,000,000 shares
of Common Stock that may be acquired at any time by those stockholders upon the
conversion of Series A Preferred Stock and (iii) 3,298 shares of Common Stock
owned by a Member and Managing Director of Warburg Pincus LLC and Partner of
Warburg Pincus & Co.
(2) Includes 20,000,000 shares of Common Stock that may be acquired at any
time upon the conversion of Series A Preferred Stock and 30,000,000 shares of
Common Stock that may be acquired within 60 days pursuant to the Preferred
Stock Warrants and Common Stock Warrants and 3,298 shares of Common Stock owned
by a Member and Managing Director of Warburg Pincus LLC and Partner of Warburg
Pincus & Co.
(3) Calculated in accordance with Rule 13d-3 under the Exchange Act, based
upon the number of shares of Common Stock outstanding as of August 31, 2001 (as
represented by the issuer in the Purchase Agreement) and including shares
issuable within 60 days to the Reporting Persons.
--------------------------------------------------------------------------------
CUSIP No. 30049P104
13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Warburg Pincus LLC I.R.S. #13-3536050
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |X|
3 SEC USE ONLY
4 SOURCE OF FUNDS*
N/A
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) |_|
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICIALLY OWNED BY EACH 0
REPORTING PERSON WITH
8 SHARED VOTING POWER
62,773,430(1)
9 SOLE DISPOSITIVE POWER
0
10 SHARED DISPOSITIVE POWER
50,003,298(2)
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
62,773,430(1)
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
68.1%(3)
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
[*SEE INSTRUCTIONS BEFORE FILLING OUT!]
--------------------------------------------------------------------------------
--------
(1) Includes (i) 20,000,000 shares of Common Stock that may be acquired at
any time upon the conversion of Series A Preferred Stock currently held by
Warburg Pincus Private Equity VIII, L.P. and 30,000,000 shares of Common Stock
that may be acquired within 60 days pursuant to the Preferred Stock Warrants
and Common Stock Warrants (discussed in Items 3-5); (ii) 10,770,132 shares of
Common Stock currently held by certain other stockholders of the issuer that
are subject to the Voting Agreement (discussed in Item 6) and 2,000,000 shares
of Common Stock that may be acquired at any time by those stockholders upon the
conversion of Series A Preferred Stock and (iii) 3,298 shares of Common Stock
owned by a Member and Managing Director of Warburg Pincus LLC and Partner of
Warburg Pincus & Co.
(2) Includes 20,000,000 shares of Common Stock that may be acquired at any
time upon the conversion of Series A Preferred Stock and 30,000,000 shares of
Common Stock that may be acquired within 60 days pursuant to the Preferred
Stock Warrants and Common Stock Warrants and 3,298 shares of Common Stock owned
by a Member and Managing Director of Warburg Pincus LLC and Partner of Warburg
Pincus & Co.
(3) Calculated in accordance with Rule 13d-3 under the Exchange Act, based
upon the number of shares of Common Stock outstanding as of August 31, 2001 (as
represented by the issuer in the Purchase Agreement) and including shares
issuable within 60 days to the Reporting Persons.
This Amendment No. 1 ("Amendment No. 1") to that certain statement on
Schedule 13D of Warburg Pincus Private Equity VIII, L.P., a Delaware limited
partnership ("WP VIII"), Warburg Pincus LLC, a New York limited liability
company ("WP LLC") and Warburg, Pincus & Co., a New York general partnership
("WP," and together with WP VIII and WP LLC, the "Reporting Persons") filed on
October 3, 2001 (the "Original Statement") hereby amends and restates the
Original Statement as provided herein. Capitalized terms used herein and not
otherwise defined shall have the meanings set forth in the Original Statement.
Items 3, 5 and 6 of the Original Statement are hereby amended and restated
in their entirety as follows:
Item 3. Source and Amount of Funds or Other Consideration.
Pursuant to the Series A Preferred Stock Purchase Agreement (the "Purchase
Agreement") attached hereto as Exhibit 2, dated as of September 23, 2001, by
and between WP VIII, the Company and certain other investors named in the
Schedule of Purchasers to the Purchase Agreement, (1) WP VIII purchased
1,000,000 shares of the Company's Series A Preferred Stock (the "Series A
Preferred Stock") at a price of $10 per share, with the purchase price paid in
cash on October 9, 2001 (the "Closing Date"); (2) the Company issued to WP VIII
warrants to purchase up to an aggregate of 1,000,000 additional shares of
Series A Preferred Stock at a price of $10 per share in cash, which warrants
are exercisable for up to one year after the Closing Date in certain
circumstances, in the forms attached hereto as Exhibit 3 ("Preferred Stock
Warrants"); (3) the Company issued to WP VIII a warrant to purchase up to
5,000,000 shares of Common Stock at a price of $1.00 per share in the form
attached hereto as Exhibit 4 ("Common Stock Warrant") and (4) the Company
agreed to grant to WP VIII additional Common Stock Warrants to purchase that
number of shares of Common Stock equal to 25% of the number of shares of Common
Stock into which the shares of Series A Preferred Stock issued upon exercise of
the Preferred Stock Warrants are convertible, at the time such Preferred Stock
Warrants are exercised. Each share of Series A Preferred Stock will be
convertible into Common Stock at an initial conversion price of $0.50, or at an
initial conversion rate of 20 shares of Common Stock for each share of Series A
Preferred Stock converted, subject to certain adjustments as set forth in the
Certificate of Designation of Series A Preferred Stock of the Company, attached
hereto as Exhibit 5 (the "Certificate of Designation").
The total amount of funds used to purchase the Series A Preferred Stock
pursuant to the Purchase Agreement was $10,000,000 and was furnished from the
working capital of WP VIII. If WP VIII elects to exercise the Preferred Stock
Warrants in full, the total amount of funds that will be required to purchase
the additional shares of Series A Preferred Stock issuable upon such exercise
will be $10,000,000, which will be furnished from the working capital of WP
VIII. If WP VIII elects to exercise the Common Stock Warrants in full for cash,
the total amount of funds that will be required to purchase the Common Stock
pursuant to such warrants will be $5,000,000 ($10,000,000 if the Preferred
Stock Warrants are exercised in full), which will be provided from the working
capital of WP VIII. However, the Common Stock Warrants provide WP VIII the
option to convert such warrants on a cashless basis by electing to have the
Company withhold a number of shares otherwise issuable upon exercise of the
Warrants that is equal in value at the time of conversion to the aggregate
exercise price of the Common Stock Warrants. WP VIII has not made any
determination as to whether it would exercise the Common Stock Warrants, if at
all, either for cash or on a cashless basis. Except as otherwise expressly
stated, all shares are reported on a common stock equivalent basis, assuming
that all warrants issued or issuable pursuant to the Purchase Agreement are
exercised in full for cash.
Item 5. Interest in Securities of the Issuer.
(a) Assuming (i) exercise of all Preferred Stock Warrants issued to WP
VIII; (ii) full conversion of the shares of Series A Preferred Stock issued to
WP VIII at the closing and issuable pursuant to the Preferred Stock Warrants
and (iii) full exercise for cash of all Common Stock Warrants issuable to WP
VIII at the closing and upon exercise of the Preferred Stock Warrants, WP VIII
may be deemed to beneficially own 50,000,000 shares of Common Stock,
representing approximately 55.5% of the outstanding shares of Common Stock,
based on the 40,166,616 shares of Common Stock outstanding as of August 31,
2001 (which number was represented by the Company in the Purchase Agreement to
be outstanding on that date), calculated in accordance with Rule 13d-3 under
the Exchange Act. By reason of their respective relationships with WP VIII and
each other, each of the other Reporting Persons may also be deemed under Rule
13d-3 under the Exchange Act to own beneficially 50,000,000 shares of Common
Stock, representing approximately 55.5% of the outstanding Common Stock. Until
such time as the Common Stock Warrant and the Preferred Stock Warrants are
exercised, the Reporting Persons disclaim beneficial ownership of any shares of
Common Stock issuable thereon.
One Member and Managing Director of WP LLC and Partner of WP owns
approximately 3,298 shares of Common Stock. The Reporting Persons expressly
disclaim beneficial ownership of these shares.
In addition, and as described in Item 6, WP VIII has entered into voting
agreements with the beneficial owners of 12,770,132 shares of Common Stock (the
"Voting Agreement Shares"), pursuant to which WP VIII may be deemed a
beneficial owner of such shares. Taking into account the Voting Agreement
Shares, together with the Common Stock issuable upon conversion of Series A
Preferred Stock and exercise of Common Stock Warrants issuable to WP VIII and
held by the Member and Managing Director of WP LLC and Partner of WP, WP VIII
may be deemed the beneficial owner of an aggregate of 62,773,430 shares of
Common Stock, or 68.1% of the Company's Common Stock, calculated in accordance
with Rule 13d-3. WP VIII expressly disclaims beneficial ownership of the Voting
Agreement Shares.
(b) WP and WP LLC share with WP VIII the power to vote or to direct the
vote and to dispose or to direct the disposition of the 62,773,430 shares of
Common Stock it may be deemed to beneficially own.
The Reporting Persons are making this single, joint filing because they
may be deemed to constitute a "group" within the meaning of Section 13(d)(3) of
the Exchange Act. Each Reporting Person disclaims beneficial ownership of all
shares of Common Stock, other than those reported herein as being owned by it.
(c) Other than as set forth in Item 4 hereof, no transactions in the
Common Stock were effected during the last sixty days by the Reporting Persons
or any of the persons set forth on Schedule I or in Item 2(d) hereto.
(d) Except as set forth in this Item 5, no person other than each
respective record owner referred to herein of securities is known to have the
right to receive or the power to direct the receipt of dividends from, or the
proceeds from the sale of, such securities.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships With
Respect to the Securities of the Issuer.
Pursuant to Rule 13d-1(k) promulgated under the Exchange Act, the
Reporting Persons have entered into an agreement attached hereto as Exhibit 1,
with respect to the joint filing of this statement and any amendment or
amendments hereto.
As an inducement to WP VIII to enter into the Purchase Agreement, on
September 23, 2001, Sierra Ventures Group, John P. Bantleman, James J. Bozzini,
John Oltman, Kurt Heikkinen, Joseph A. Fuca, Jeff Drazan, Paul Rochester,
Judith Hamilton, Kenneth J. Bozzini, David Hsieh and Ian Reay (the
"Stockholders") of the Company, who collectively own (i) 10,770,132 shares of
the Company's Common Stock and (ii) Series A Preferred Stock that can be
converted into 2,000,000 shares of Common Stock at any time, entered into a
voting agreement (the "Voting Agreement") with WP VIII in the form attached
hereto as Exhibit 7. Pursuant to the Voting Agreement, each of the stockholders
agreed to vote (or cause to be voted) all of the shares of the Company's stock
owned or acquired by them at any meeting of the stockholders of the Company,
and in any action by written consent of the stockholders of the Company, (i) in
favor of the approval of the transactions contemplated by the Purchase
Agreement including the issuance of capital stock of the Company pursuant
thereto, (ii) in favor, to the extent it is necessary, of an increase in the
number of authorized, but unissued, shares of Company Common Stock, in an
amount determined by the Company's Board of Directors, (iii) in favor, if
proposed by the Company's Board of Directors, of a reverse stock split of the
Company's Common Stock, and (iv) in favor of any other matter directly relating
to and in furtherance of consummation of the transactions contemplated by the
Purchase Agreement. The Voting Agreement will terminate upon the earliest to
occur of the approval by the Company's stockholders of each of the matters
described above, the termination of the Purchase Agreement according to its
terms and the termination of the Voting Agreement by mutual consent of the
parties. This summary of the Voting Agreement is qualified in its entirety by
reference to the form of Voting Agreement attached as Exhibit 7 hereto.
In addition to their outstanding shares of Common Stock, the Reporting
Persons have been advised by the Company that the Stockholders have rights to
acquire an aggregate of 3,384,164 shares of common stock within 60 days of the
date of this filing. Any shares of common stock acquired by any stockholder
after the date hereof and prior to the termination of the Voting Agreement
would be subject to the Voting Agreement.
The Purchase Agreement and the agreements, contemplated thereby were
entered into as of September 23, 2001 and is described in Item 3, Item 4 and
Item 5 above.
Except as described above, there are no contracts, arrangements,
understandings or relationships (legal or otherwise) among the persons named in
Item 2 above or between such persons and any other person with respect to any
securities of the Company.
Item 7. Material to be Filed as Exhibits
1. Joint Filing Agreement*
2. Series A Preferred Stock Purchase Agreement, dated as of September
23, 2001, by and between the Company, WP VIII and certain other
persons.*
3. Form of Form A Subscription Warrant and Form of Form B Subscription
Warrant.*
4. Form of Warrant to Purchase Shares of Common Stock.*
5. Form of Certificate of Designation of Series A Preferred Stock of
Evolve Software, Inc. *
6. Form of Preemptive Rights Agreement between the Company, WP VIII and
certain other persons.*
7. Form of Voting Agreement between WP VIII and certain stockholders of
the Company.*
8. Power of Attorney.*
-----------------
* Previously filed
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: October 16, 2001 WARBURG PINCUS PRIVATE EQUITY VIII, L.P.
By: Warburg, Pincus & Co.,
General Partner
By: /s/ Scott Arenare
-----------------
Name: Scott Arenare
Title: Attorney in Fact
Dated: October 16, 2001 WARBURG PINCUS & Co.
By: /s/ Scott Arenare
-----------------
Name: Scott Arenare
Title: Attorney in Fact
Dated: October 16, 2001 WARBURG PINCUS LLC
By: /s/ Scott Arenare
-----------------
Name: Scott Arenare
Title: Vice President
SCHEDULE I
Set forth below is the name, position and present principal occupation of
each of the general partners of Warburg, Pincus & Co. ("WP") and members of
Warburg Pincus LLC ("WP LLC"). The sole general partner of Warburg, Pincus
Private Equity VIII ("WP VIII") is WP. WP VIII, WP, and WP LLC are hereinafter
collectively referred to as the "Reporting Entities". Except as otherwise
indicated, the business address of each of such persons is 466 Lexington
Avenue, New York, New York 10017, and each of such persons is a citizen of the
United States.
GENERAL PARTNERS OF WP
PRESENT PRINCIPAL OCCUPATION IN ADDITION TO
POSITION WITH WP, AND POSITIONS WITH THE
NAME REPORTING ENTITIES
Joel Ackerman Partner of WP; Member and Managing Director of WP LLC
Gregory Back Partner of WP; Member and Managing Director of WP LLC
David Barr Partner of WP; Member and Managing Director of WP LLC
Harold Brown Partner of WP; Member and Managing Director of WP LLC
Sean D. Carney Partner of WP; Member and Managing Director of WP LLC
Timothy J. Curt Partner of WP; Member and Managing Director of WP LLC
W. Bowman Cutter Partner of WP; Member and Managing Director of WP LLC
Cary J. Davis Partner of WP; Member and Managing Director of WP LLC
Stephen Distler Partner of WP; Member and Managing Director of WP LLC
Stewart K. P. Gross Partner of WP; Member and Senior Managing Director of WP LLC
Patrick T. Hackett Partner of WP; Member and Managing Director of WP LLC
Jeffrey A. Harris Partner of WP; Member and Senior Managing Director of WP LLC
William H. Janeway Partner of WP; Member and Vice Chairman of WP LLC
Charles R. Kaye Partner of WP; Member and Executive Managing Director of WP
LLC
Henry Kressel Partner of WP; Member and Senior Managing Director of WP LLC
Joseph P. Landy Partner of WP; Member and Executive Managing Director WP LLC
Sidney Lapidus Partner of WP; Member and Managing Director of WP LLC
Kewsong Lee Partner of WP; Member and Managing Director of WP LLC
Jonathan S. Leff Partner of WP; Member and Managing Director of WP LLC
Reuben S. Leibowitz Partner of WP; Member and Managing Director of WP LLC
David E. Libowitz Partner of WP; Member and Managing Director of WP LLC
Nancy Martin Partner of WP; Member and Managing Director of WP LLC
Edward J. McKinley Partner of WP; Member and Managing Director of WP LLC
Rodman W. Moorhead III Partner of WP; Member and Managing Director of WP LLC
James Neary Partner of WP; Member and Managing Director of WP LLC
Howard H. Newman Partner of WP; Member and Vice Chairman of WP LLC
Gary D. Nusbaum Partner of WP; Member and Managing Director of WP LLC
Dalip Pathak Partner of WP; Member and Managing Director of WP LLC
Lionel I. Pincus Managing Partner of WP; Managing Member, Chairman of the
Board and Chief Executive Officer of WP LLC
John D. Santoleri Partner of WP; Member and Managing Director of WP LLC
Steven G. Schneider Partner of WP; Member and Managing Director of WP LLC
Barry Taylor Partner of WP; Member and Managing Director of WP LLC
John L. Vogelstein Partner of WP; Member, and President of WP LLC
PRESENT PRINCIPAL OCCUPATION IN ADDITION TO
POSITION WITH WP, AND POSITIONS WITH THE
NAME REPORTING ENTITIES
Elizabeth H. Weatherman Partner of WP; Member and Managing Director of WP LLC
David Wenstrup Partner of WP; Member and Managing Director of WP LLC
Pincus & Co.(1)
NL & Co.(2)
--------
(1) New York limited partnership; primary activity is ownership interest in WP
and WP LLC
(2) New York limited partnership; primary activity is ownership interest in
WP.
MEMBERS OF WP LLC
PRESENT PRINCIPAL OCCUPATION IN ADDITION TO
POSITION WITH WP LLC, AND POSITIONS WITH THE
NAME REPORTING ENTITIES
Joel Ackerman Member and Managing Director of WP LLC; Partner of WP
Gregory Back Member and Managing Director of WP LLC; Partner of WP
David Barr Member and Managing Director of WP LLC; Partner of WP
Frank M. Brochin (1) Member and Managing Director of WP LLC
Harold Brown Member and Managing Director of WP LLC; Partner of WP
Sean D. Carney Member and Managing Director of WP LLC; Partner of WP
Timothy J. Curt Member and Managing Director of WP LLC; Partner of WP
W. Bowman Cutter Member and Managing Director of WP LLC; Partner of WP
Cary J. Davis Member and Managing Director of WP LLC; Partner of WP
Stephen Distler Member and Managing Director of WP LLC; Partner of WP
Tetsuya Fukagawa (2) Member and Managing Director of WP LLC
Makoto Fukuhara (2) Member and Managing Director of WP LLC
Stewart K. P. Gross Member and Senior Managing Director of WP LLC; Partner of WP
Alf Grunwald (3) Member and Managing Director of WP LLC
Patrick T. Hackett Member and Managing Director of WP LLC; Partner of WP
Jeffrey A. Harris Member and Senior Managing Director of WP LLC; Partner of WP
Sung-Jin Hwang (4) Member and Managing Director of WP LLC
Roberto Italia (5) Member and Managing Director of WP LLC
William H. Janeway Member and Vice Chairman of WP LLC; Partner of WP
Charles R. Kaye Member and Executive Managing Director of WP LLC; Partner of
WP
Rajesh Khanna (6) Member and Managing Director of WP LLC
Henry Kressel Member and Senior Managing Director of WP LLC; Partner of WP
Rajiv B. Lall (6) Member and Managing Director of WP LLC
Joseph P. Landy Member and Executive Managing Director of WP LLC; Partner of
WP
Sidney Lapidus Member and Managing Director of WP LLC; Partner of WP
Kewsong Lee Member and Managing Director of WP LLC; Partner of WP
Jonathan S. Leff Member and Managing Director of WP LLC; Partner of WP
Reuben S. Leibowitz Member and Managing Director of WP LLC; Partner of WP
David E. Libowitz Member and Managing Director of WP LLC; Partner of WP
Nicholas J. Lowcock (7) Member and Managing Director of WP LLC
John W. MacIntosh (8) Member and Managing Director of WP LLC
Nancy Martin Member and Managing Director of WP LLC; Partner of WP
Edward J. McKinley Member and Managing Director of WP LLC; Partner of WP
Rodman W. Moorhead III Member and Managing Director of WP LLC; Partner of WP
James Neary Member and Managing Director of WP LLC; Partner of WP
Howard H. Newman Member and Vice Chairman of WP LLC; Partner of WP
Gary D. Nusbaum Member and Managing Director of WP LLC; Partner of WP
Dalip Pathak Member and Managing Director of WP LLC; Partner of WP
Lionel I. Pincus Managing Member, Chairman of the Board and Chief Executive
Officer of WP LLC; Managing Partner of WP
Pulak Chandan Prasad (6) Member and Managing Director of WP LLC
PRESENT PRINCIPAL OCCUPATION IN ADDITION TO
POSITION WITH WP LLC, AND POSITIONS WITH THE
NAME REPORTING ENTITIES
John D. Santoleri Member and Managing Director of WP LLC; Partner of WP
Steven G. Schneider Member and Managing Director of WP LLC; Partner of WP
Melchior Stahl (3) Member and Managing Director of WP LLC
Chang Q. Sun (9) Member and Managing Director of WP LLC
Barry Taylor Member and Managing Director of WP LLC, Partner of WP
John L. Vogelstein Member and President of WP LLC; Partner of WP
Elizabeth H. Weatherman Member and Managing Director of WP LLC; Partner of WP
David Wenstrup Member and Managing Director of WP LLC; Partner of WP
Jeremy S. Young (7) Member and Managing Director of WP LLC
Pincus & Co.(1)
(1) Citizen of France
(2) Citizen of Japan
(3) Citizen of Germany
(4) Citizen of Korea
(5) Citizen of Italy
(6) Citizen of India
(7) Citizen of United Kingdom
(8) Citizen of Canada
(9) Citizen of China
--------
(1) New York limited partnership; primary activity is ownership interest in WP
and EMW LLC
Exhibit Index
1. Joint Filing Agreement*
2. Series A Preferred Stock Purchase Agreement, dated as of September 23,
2001, by and between the Company, WP VIII and certain other persons.*
3. Form of Form A Subscription Warrant and Form of Form B Subscription
Warrant.*
4. Form of Warrant to Purchase Shares of Common Stock.*
5. Form of Certificate of Designation of Series A Preferred Stock of Evolve
Software, Inc. *
6. Form of Preemptive Rights Agreement between the Company, WP VIII and
certain other persons.*
7. Form of Voting Agreement between WP VIII and certain stockholders of the
Company.*
8. Power of Attorney.*
-----------------
* Previously filed